Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT, USA
Yale School of Public Health, New Haven, CT, USA.
BMJ. 2022 Jun 27;377:e069271. doi: 10.1136/bmj-2021-069271.
To determine the effect of a user centered clinical decision support tool versus usual care on rates of initiation of buprenorphine in the routine emergency care of individuals with opioid use disorder.
Pragmatic cluster randomized controlled trial (EMBED).
18 emergency department clusters across five healthcare systems in five states representing the north east, south east, and western regions of the US, ranging from community hospitals to tertiary care centers, using either the Epic or Cerner electronic health record platform.
599 attending emergency physicians caring for 5047 adult patients presenting with opioid use disorder.
A user centered, physician facing clinical decision support system seamlessly integrated into user workflows in the electronic health record to support initiating buprenorphine in the emergency department by helping clinicians to diagnose opioid use disorder, assess the severity of withdrawal, motivate patients to accept treatment, and complete electronic health record tasks by automating clinical and after visit documentation, order entry, prescribing, and referral.
Rate of initiation of buprenorphine (administration or prescription of buprenorphine) in the emergency department among patients with opioid use disorder. Secondary implementation outcomes were measured with the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework.
1 413 693 visits to the emergency department (775 873 in the intervention arm and 637 820 in the usual care arm) from November 2019 to May 2021 were assessed for eligibility, resulting in 5047 patients with opioid use disorder (2787 intervention arm, 2260 usual care arm) under the care of 599 attending physicians (340 intervention arm, 259 usual care arm) for analysis. Buprenorphine was initiated in 347 (12.5%) patients in the intervention arm and in 271 (12.0%) patients in the usual care arm (adjusted generalized estimating equations odds ratio 1.22, 95% confidence interval 0.61 to 2.43, P=0.58). Buprenorphine was initiated at least once by 151 (44.4%) physicians in the intervention arm and by 88 (34.0%) in the usual care arm (1.83, 1.16 to 2.89, P=0.01).
User centered clinical decision support did not increase patient level rates of initiating buprenorphine in the emergency department. Although streamlining and automating electronic health record workflows can potentially increase adoption of complex, unfamiliar evidence based practices, more interventions are needed to look at other barriers to the treatment of addiction and increase the rate of initiating buprenorphine in the emergency department in patients with opioid use disorder.
ClinicalTrials.gov NCT03658642.
确定以用户为中心的临床决策支持工具与常规护理相比,在常规急诊护理中启动丁丙诺啡治疗阿片类药物使用障碍患者的效果。
实用的聚类随机对照试验(EMBED)。
美国东北部、东南部和西部五个州的五个医疗系统的 18 个急诊部集群,包括社区医院到三级护理中心,使用 Epic 或 Cerner 电子病历平台。
599 名主治急诊医生为 5047 名成年阿片类药物使用障碍患者就诊。
以用户为中心,面向医生的临床决策支持系统无缝集成到电子病历的用户工作流程中,通过帮助临床医生诊断阿片类药物使用障碍、评估戒断严重程度、鼓励患者接受治疗以及通过自动化临床和就诊后文档、医嘱输入、处方和转诊来完成电子病历任务,从而支持在急诊室启动丁丙诺啡。
阿片类药物使用障碍患者在急诊室启动丁丙诺啡的比例(丁丙诺啡的管理或处方)。次要实施结果是使用 RE-AIM(范围、效果、采用、实施和维持)框架进行测量的。
2019 年 11 月至 2021 年 5 月,对急诊部的 1413693 次就诊进行了评估,以确定是否符合条件,共纳入 5047 名阿片类药物使用障碍患者(干预组 2787 名,常规护理组 2260 名),由 599 名主治医生(干预组 340 名,常规护理组 259 名)进行护理,进行分析。在干预组中,有 347 名(12.5%)患者开始使用丁丙诺啡,在常规护理组中,有 271 名(12.0%)患者开始使用丁丙诺啡(调整后的广义估计方程比值比 1.22,95%置信区间 0.61 至 2.43,P=0.58)。在干预组中,有 151 名(44.4%)医生至少开出了一次丁丙诺啡,在常规护理组中有 88 名(34.0%)医生开出了丁丙诺啡(1.83,1.16 至 2.89,P=0.01)。
以用户为中心的临床决策支持并没有增加患者在急诊室开始使用丁丙诺啡的比例。虽然简化和自动化电子病历工作流程有可能增加对复杂、不熟悉的循证实践的采用,但还需要更多的干预措施来研究治疗成瘾的其他障碍,并提高阿片类药物使用障碍患者在急诊室开始使用丁丙诺啡的比例。
ClinicalTrials.gov NCT03658642。